How Cell And Gene Therapies Are Advancing Collaborations In Biopharma

By Sophia Ononye - Onyia

The last time I wrote for Life Science Leader (“er Why Collaboration Is Key To Success For 3D Bioprinting And Regenerative Medicine”), I highlighted the importance of collaboration in the field of regenerative medicine. Roughly two years later, I felt it would be illuminating to reassess how these collaborations are elevating the state of science as well as diversity initiatives with a focus on cell and gene therapies (CGTs).